Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.
CONCLUSION: ICIs appear to be effective in sccRCC while the treatment of snccRCC remains challenging.
PMID: 33187886 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Chahoud J, Msaouel P, Ross JA, McCormick BZ, Bathala TK, Gao J, Horn R, Xiao L, Sircar K, Campbell MT, Shah AY, Goswami S, Zurita AJ, Jonasch E, Matin SF, Wood CG, Karam JA, Sharma P, Tannir NM Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Kidney Cancer | Renal Cell Carcinoma | Science | Urology & Nephrology